BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Queensland Health
US Army
Fish and Richardson
US Department of Justice
Farmers Insurance
Chinese Patent Office

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,753,706

« Back to Dashboard

Which drugs does patent 5,753,706 protect, and when does it expire?

Patent 5,753,706 protects AURYXIA and is included in one NDA.

This patent has fifteen patent family members in twelve countries.

Summary for Patent: 5,753,706

Title: Methods for treating renal failure
Abstract:Methods of controlling phosphate metabolism and metabolic acidosis in patients suffering from renal failure and associated hyperphosphatemia or patients predisposed to development of a hyperphosphatemic condition are provided. The method in accordance with this invention comprises administering to a patient a ferric-containing compound selected from the group consisting of ferric citrate, ferric acetate, and combinations thereof. Therapeutic benefit can be realized in accordance with such method by administering the compound orally to a patient to contact and bind with ingested phosphate in the patient's digestive tract, and thereby prevent its intestinal absorption.
Inventor(s): Hsu; Chen Hsing (Ann Harbor, MI)
Application Number:08/794,328
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Keryx BiopharmsAURYXIAferric citrateTABLET;ORAL205874-001Sep 5, 2014RXYesYes► Subscribe► SubscribeYCONTROL OF SERUM PHOSPHOROUS LEVELS► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 5,753,706

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Norway992936► Subscribe
South Korea100464504► Subscribe
Japan2007217429► Subscribe
Japan4173553► Subscribe
Japan2001506262► Subscribe
Israel130041► Subscribe
Spain2310417► Subscribe
European Patent Office0959878► Subscribe
Denmark0959878► Subscribe
Germany69738824► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Argus Health
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: